| Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty. | |
| | |
MedLine Citation:
|
PMID: 19056224 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Autologous blood donation and erythropoietin (EPO) have been shown to be effective in reducing allogeneic blood transfusion, but the cost-effectiveness of these interventions remains unclear. A cost minimization analysis was performed, comparing the total costs of allogeneic blood transfusion strategy and autologous and allogeneic blood transfusion strategy for 161 primary total hip arthroplasty (THA) and 195 total knee arthroplasty (TKA) patients. An EPO cost minimization model was constructed using a previously published algorithm for blood management after total joint arthroplasty. The least costly strategy was autologous blood donation in combination with allogeneic blood for THA and TKA patients at $856 and $892 per patient, respectively. The most costly strategy was allogeneic only at $1769 and $1352 per THA and TKA patient, respectively. The EPO strategy model predicted costs similar to the autologous and allogeneic. A strategy that combines autologous blood donation with EPO for patients who cannot donate autologous blood may provide the greatest cost savings and minimize allogeneic blood transfusion. |
| | |
Authors:
|
William Scott Green; Pearl Toy; Kevin J Bozic |
Related Documents
:
|
1390614 - Effect of ileo-rectal anastomosis and post-valve t-caecum cannulation on growing pigs. ... 16320014 - Patella intraosseous blood flow disturbance during a medial or lateral arthrotomy in to... 11561504 - Reinfusion of drained blood as an alternative to homologous blood transfusion after tot... 1853444 - An autologous blood program coordinated by a regional blood center: a 5-year experience. 11414314 - Differential effects of et-1, et-2, and et-3 on pancreatic microcirculation, tissue int... 1201744 - Maximal steady state versus state of conditioning. |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2008-12-03 |
Journal Detail:
|
Title: The Journal of arthroplasty Volume: 25 ISSN: 1532-8406 ISO Abbreviation: J Arthroplasty Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-02-01 Completed Date: 2010-04-22 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8703515 Medline TA: J Arthroplasty Country: United States |
Other Details:
|
Languages: eng Pagination: 93-6 Citation Subset: IM |
Copyright Information:
|
2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Orthopedic Surgery, University of California San Francisco, San Francisco, California 94143, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arthroplasty, Replacement, Hip* Arthroplasty, Replacement, Knee* Blood Transfusion / economics* Blood Transfusion, Autologous / economics* Cost Savings Cost-Benefit Analysis Costs and Cost Analysis Erythropoietin, Recombinant / administration & dosage, economics* Hemoglobins / analysis Humans Middle Aged Preoperative Care* |
| Chemical | |
Reg. No./Substance:
|
0/Erythropoietin, Recombinant; 0/Hemoglobins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Internal Fixation After Subtrochanteric Femoral Fracture After Hip Resurfacing Arthroplasty.
Next Document: Minimum 5-Year Results in 96 Consecutive Hips Treated with a Tapered Titanium Stem System.